Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3375 | 1998 | 44.7 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
133 | 3 | MELATONIN//SLEEP//JOURNAL OF PINEAL RESEARCH | 66554 |
1753 | 2 | OREXIN//GALANIN//HYPOCRETIN | 6481 |
3375 | 1 | GALANIN//GALANIN RECEPTOR//GALANIN LIKE PEPTIDE | 1998 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GALANIN | authKW | 7703738 | 39% | 65% | 770 |
2 | GALANIN RECEPTOR | authKW | 1545636 | 5% | 96% | 105 |
3 | GALANIN LIKE PEPTIDE | authKW | 525375 | 2% | 90% | 38 |
4 | GALANTIDE | authKW | 321568 | 1% | 96% | 22 |
5 | GALANIN ANTAGONIST | authKW | 229218 | 1% | 100% | 15 |
6 | GALANIN FRAGMENT | authKW | 183374 | 1% | 100% | 12 |
7 | GALANIN RECEPTOR 1 | authKW | 168093 | 1% | 100% | 11 |
8 | LAURA BASSI EXPERTISE THER EP | address | 166389 | 1% | 78% | 14 |
9 | GALNON | authKW | 152812 | 1% | 100% | 10 |
10 | GALR2 | authKW | 152812 | 1% | 100% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 13516 | 48% | 0% | 957 |
2 | Endocrinology & Metabolism | 10990 | 29% | 0% | 580 |
3 | Pharmacology & Pharmacy | 992 | 15% | 0% | 304 |
4 | Physiology | 862 | 8% | 0% | 161 |
5 | Biochemistry & Molecular Biology | 447 | 17% | 0% | 332 |
6 | Behavioral Sciences | 180 | 3% | 0% | 52 |
7 | Psychology, Biological | 81 | 1% | 0% | 17 |
8 | Anatomy & Morphology | 80 | 1% | 0% | 21 |
9 | Medicine, Research & Experimental | 74 | 4% | 0% | 70 |
10 | Cell Biology | 58 | 5% | 0% | 99 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LAURA BASSI EXPERTISE THER EP | 166389 | 1% | 78% | 14 |
2 | NEUROCHEM NEUROTOXICOL | 120171 | 2% | 21% | 37 |
3 | COMBINING CHINESE TRADIT WESTERN MED | 117543 | 1% | 77% | 10 |
4 | CHINESE MED HANLIN | 76406 | 0% | 100% | 5 |
5 | HANLIN | 70969 | 1% | 39% | 12 |
6 | SECT BEHAV GENOM | 69850 | 0% | 57% | 8 |
7 | SECT BEHAV NEUROPHARMACOL | 62855 | 1% | 34% | 12 |
8 | MOLEC INTEGRAT NEUROSCI | 62392 | 0% | 58% | 7 |
9 | TAIZHOU HOSP TRADIT CHINESE MED | 61125 | 0% | 100% | 4 |
10 | CHEM NEUROTRANSMISS | 54573 | 0% | 71% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROPEPTIDES | 54264 | 5% | 4% | 95 |
2 | REGULATORY PEPTIDES | 15334 | 3% | 1% | 69 |
3 | PEPTIDES | 10800 | 4% | 1% | 79 |
4 | JOURNAL OF NEUROENDOCRINOLOGY | 7269 | 2% | 1% | 39 |
5 | NEUROENDOCRINOLOGY | 5591 | 2% | 1% | 41 |
6 | JOURNAL OF CHEMICAL NEUROANATOMY | 4306 | 1% | 1% | 19 |
7 | NEUROSCIENCE LETTERS | 4132 | 5% | 0% | 93 |
8 | ENDOCRINOLOGY | 3647 | 4% | 0% | 78 |
9 | NEUROSCIENCE | 3414 | 4% | 0% | 71 |
10 | BRAIN RESEARCH | 2157 | 4% | 0% | 84 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GALANIN | 7703738 | 39% | 65% | 770 | Search GALANIN | Search GALANIN |
2 | GALANIN RECEPTOR | 1545636 | 5% | 96% | 105 | Search GALANIN+RECEPTOR | Search GALANIN+RECEPTOR |
3 | GALANIN LIKE PEPTIDE | 525375 | 2% | 90% | 38 | Search GALANIN+LIKE+PEPTIDE | Search GALANIN+LIKE+PEPTIDE |
4 | GALANTIDE | 321568 | 1% | 96% | 22 | Search GALANTIDE | Search GALANTIDE |
5 | GALANIN ANTAGONIST | 229218 | 1% | 100% | 15 | Search GALANIN+ANTAGONIST | Search GALANIN+ANTAGONIST |
6 | GALANIN FRAGMENT | 183374 | 1% | 100% | 12 | Search GALANIN+FRAGMENT | Search GALANIN+FRAGMENT |
7 | GALANIN RECEPTOR 1 | 168093 | 1% | 100% | 11 | Search GALANIN+RECEPTOR+1 | Search GALANIN+RECEPTOR+1 |
8 | GALNON | 152812 | 1% | 100% | 10 | Search GALNON | Search GALNON |
9 | GALR2 | 152812 | 1% | 100% | 10 | Search GALR2 | Search GALR2 |
10 | GALANIN 1 15 | 122250 | 0% | 100% | 8 | Search GALANIN+1+15 | Search GALANIN+1+15 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LANG, R , GUNDLACH, AL , HOLMES, FE , HOBSON, SA , WYNICK, D , HOKFELT, T , KOFLER, B , (2015) PHYSIOLOGY, SIGNALING, AND PHARMACOLOGY OF GALANIN PEPTIDES AND RECEPTORS: THREE DECADES OF EMERGING DIVERSITY.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 1. P. 118 -175 | 553 | 74% | 31 |
2 | LANG, R , GUNDLACH, AL , KOFLER, B , (2007) THE GALANIN PEPTIDE FAMILY: RECEPTOR PHAN-NACOLOGY, PLEIOTROPIC BIOLOGICAL ACTIONS, AND IMPLICATIONS IN HEALTH AND DISEASE.PHARMACOLOGY & THERAPEUTICS. VOL. 115. ISSUE 2. P. 177 -207 | 330 | 89% | 167 |
3 | LUNDSTROM, L , ELMQUIST, A , BARTFAI, T , LANGEL, U , (2005) GALANIN AND ITS RECEPTORS IN NEUROLOGICAL DISORDERS.NEUROMOLECULAR MEDICINE. VOL. 7. ISSUE 1-2. P. 157-180 | 183 | 88% | 49 |
4 | FANG, PH , HE, BA , SHI, MY , KONG, GM , DONG, XY , ZHU, Y , BO, P , ZHANG, ZW , (2015) THE REGULATIVE EFFECT OF GALANIN FAMILY MEMBERS ON LINK OF ENERGY METABOLISM AND REPRODUCTION.PEPTIDES. VOL. 71. ISSUE . P. 240 -249 | 148 | 86% | 3 |
5 | BARTFAI, T , HOKFELT, T , LANGEL, U , (1993) GALANIN - A NEUROENDOCRINE PEPTIDE.CRITICAL REVIEWS IN NEUROBIOLOGY. VOL. 7. ISSUE 3-4. P. 229 -274 | 231 | 89% | 177 |
6 | MITSUKAWA, K , LU, X , BARTFAI, T , (2008) GALANIN, GALANIN RECEPTORS AND DRUG TARGETS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 65. ISSUE 12. P. 1796 -1805 | 133 | 92% | 67 |
7 | FREIMANN, K , KURRIKOFF, K , LANGEL, U , (2015) GALANIN RECEPTORS AS A POTENTIAL TARGET FOR NEUROLOGICAL DISEASE.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 19. ISSUE 12. P. 1665 -1676 | 126 | 92% | 2 |
8 | WALTON, KM , CHIN, JE , DUPLANTIER, AJ , MATHER, RJ , (2006) GALANIN FUNCTION IN THE CENTRAL NERVOUS SYSTEM.CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. VOL. 9. ISSUE 5. P. 560 -570 | 139 | 93% | 12 |
9 | CRAWLEY, JN , (1995) BIOLOGICAL ACTIONS OF GALANIN.REGULATORY PEPTIDES. VOL. 59. ISSUE 1. P. 1-16 | 168 | 92% | 117 |
10 | MCDONALD, MP , CRAWLEY, JN , (1997) GALANIN-ACETYLCHOLINE INTERACTIONS IN RODENT MEMORY TASKS AND ALZHEIMER'S DISEASE.JOURNAL OF PSYCHIATRY & NEUROSCIENCE. VOL. 22. ISSUE 5. P. 303-317 | 176 | 81% | 19 |
Classes with closest relation at Level 1 |